Recent findings from University of British Columbia highlight research in alopecia therapy
2007 JUL 31 -- Research findings, "Androgenetic alopecia," are discussed in a new report. "Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50% of the male population. AGA is an androgen-related condition in genetically predisposed individuals," researchers in Vancouver, Canada report. "There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (eg, finasteride, minoxidil, or a combination of both), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Combination with hair restoration surgery leads to best results in suitable candidates," wrote N. Otberg and colleagues, University of British Columbia. The researchers concluded: "Physicians who specialize in male health issues should be familiar with this common condition and all the available approved treatment options." Otberg and colleagues published their study in Endocrinology and Metabolism Clinics of North America (Androgenetic alopecia. Endocrinology and Metabolism Clinics of North America, 2007;36(2):379-98). For additional information, contact N. Otberg, University of British Columbia, Dept. of Dermatology and Skin Science, 835 West 10th Avenue, Vancouver, BC V5Z 4E8, Canada. Publisher contact information for the journal Endocrinology and Metabolism Clinics of North America is: W B Saunders Co., Independence Square West Curtis Center, Ste. 300, Philadelphia, PA 19106-3399, USA. Keywords: Canada, Vancouver, Alopecia Therapy, Alopecia, Endocrinology, Genetics, Metabolism. This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2007, Life Science Weekly via NewsRx.com.
|
